Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial

Ana C. Garrido-Castro, Noah Graham, Katelyn X. Li, Lynn Bi, Jett Crowdis, Kevin Bi, Jihye Park, Ricardo Pastorello, Yvonne Li, Hersh Gupta, Thomas Kuntz, Russell Petry, Lincoln W. Pasquina, Ashka Patel, Paulina Lange, Molly DiLullo, Victoria Attaya, Anna Mae Frey, Merrida A. Childress, Robert Wesolowski, Natalie Sinclair, Sarah Sinclair, Steve Lo, Nadine Tung, Meredith Faggen, Peter A. Kaufman, Caroline C. Block, Jeanna Walsh, Madhavi Toke, Wendy Chen, Kai W. Wucherpfennig, Ye Tian, Amy J. Williams, Satabhisa Mukhopadhyay, Tathagata Dasgupta, Stuart Schnitt, Andrew D. Cherniack, Romualdo Barroso, Jennifer Ligibel, Nancy U. Lin, Elizabeth A. Mittendorf, Nabihah Tayob, Eliezer Van Allen, Sara M. Tolaney

Open source

DOI: 10.1038/s41467-026-73085-1
Published: 2026-05-16
Container: Nature Communications
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41467-026-73085-1,
  title = {Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial},
  author = {Ana C. Garrido-Castro and Noah Graham and Katelyn X. Li and Lynn Bi and Jett Crowdis and Kevin Bi and Jihye Park and Ricardo Pastorello and Yvonne Li and Hersh Gupta and Thomas Kuntz and Russell Petry and Lincoln W. Pasquina and Ashka Patel and Paulina Lange and Molly DiLullo and Victoria Attaya and Anna Mae Frey and Merrida A. Childress and Robert Wesolowski and Natalie Sinclair and Sarah Sinclair and Steve Lo and Nadine Tung and Meredith Faggen and Peter A. Kaufman and Caroline C. Block and Jeanna Walsh and Madhavi Toke and Wendy Chen and Kai W. Wucherpfennig and Ye Tian and Amy J. Williams and Satabhisa Mukhopadhyay and Tathagata Dasgupta and Stuart Schnitt and Andrew D. Cherniack and Romualdo Barroso and Jennifer Ligibel and Nancy U. Lin and Elizabeth A. Mittendorf and Nabihah Tayob and Eliezer Van Allen and Sara M. Tolaney},
  year = {2026},
  journal = {Nature Communications},
  doi = {10.1038/s41467-026-73085-1},
  url = {https://doi.org/10.1038/s41467-026-73085-1}
}

RIS

TY  - JOUR
TI  - Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial
AU  - Ana C. Garrido-Castro
AU  - Noah Graham
AU  - Katelyn X. Li
AU  - Lynn Bi
AU  - Jett Crowdis
AU  - Kevin Bi
AU  - Jihye Park
AU  - Ricardo Pastorello
AU  - Yvonne Li
AU  - Hersh Gupta
AU  - Thomas Kuntz
AU  - Russell Petry
AU  - Lincoln W. Pasquina
AU  - Ashka Patel
AU  - Paulina Lange
AU  - Molly DiLullo
AU  - Victoria Attaya
AU  - Anna Mae Frey
AU  - Merrida A. Childress
AU  - Robert Wesolowski
AU  - Natalie Sinclair
AU  - Sarah Sinclair
AU  - Steve Lo
AU  - Nadine Tung
AU  - Meredith Faggen
AU  - Peter A. Kaufman
AU  - Caroline C. Block
AU  - Jeanna Walsh
AU  - Madhavi Toke
AU  - Wendy Chen
AU  - Kai W. Wucherpfennig
AU  - Ye Tian
AU  - Amy J. Williams
AU  - Satabhisa Mukhopadhyay
AU  - Tathagata Dasgupta
AU  - Stuart Schnitt
AU  - Andrew D. Cherniack
AU  - Romualdo Barroso
AU  - Jennifer Ligibel
AU  - Nancy U. Lin
AU  - Elizabeth A. Mittendorf
AU  - Nabihah Tayob
AU  - Eliezer Van Allen
AU  - Sara M. Tolaney
PY  - 2026
JO  - Nature Communications
DO  - 10.1038/s41467-026-73085-1
UR  - https://doi.org/10.1038/s41467-026-73085-1
ER  -

APA

Garrido-Castro, A. C., Graham, N., Li, K. X., Bi, L., Crowdis, J., Bi, K., Park, J., Pastorello, R., Li, Y., Gupta, H., Kuntz, T., Petry, R., Pasquina, L. W., Patel, A., Lange, P., DiLullo, M., Attaya, V., Frey, A. M., Childress, M. A., Wesolowski, R., Sinclair, N., Sinclair, S., Lo, S., Tung, N., Faggen, M., Kaufman, P. A., Block, C. C., Walsh, J., Toke, M., Chen, W., Wucherpfennig, K. W., Tian, Y., Williams, A. J., Mukhopadhyay, S., Dasgupta, T., Schnitt, S., Cherniack, A. D., Barroso, R., Ligibel, J., Lin, N. U., Mittendorf, E. A., Tayob, N., Allen, E. V., & Tolaney, S. M. (2026). Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial. Nature Communications. https://doi.org/10.1038/s41467-026-73085-1

Source records

crossref · retrieved 2026-09-26T15:56:04.645Z